Purchase Order 75N92025P00223
Award Date
6/5/25
Potential Completion Date
12/5/25
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $14,097.60 firm fixed price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide transcriptome profiling of human bone marrow core samples. The work supports the Hematology Branch at NHLBI. This is not a set-aside contract. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities. The company has a $500 million single-award Indefinite...
This is a federal purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a genomics and molecular biology services company. The contract, valued at $15,344.80, is for Psomagen to provide OLINK EXPLORE HT (partial panel use) services to support next-generation sequencing-based proteomics analysis of plasma samples from hospitalized sepsis patients. The contract is not associated...
This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, valued at $25,000.00, is a firm-fixed price Purchase Order for Psomagan to provide whole genome sequencing services in order to conduct genetic screening of VEXAS patients. The contract has no set-aside designation and is scheduled for completion by September...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $484,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Whole Genome Sequencing on DNA. The contract has a period of performance starting on May 17, 2022 through May 16, 2023 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. Psomagen Inc. will perform whole genome sequencing services on DNA samples for the National Heart...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
This is a federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID) to provide other functions for a total ceiling value of $6,000.00. The contract is a firm-fixed price purchase order with an ultimate completion date of October 23, 2013. Psomagen is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Psomagen Inc. for DNA and RNA sequencing of parental induced pluripotent stem cell (iPSC) lines. The contract has a ceiling value of $38,053.00 and a completion date of December 31, 2019. Psomagen Inc. is a wholly owned subsidiary of the larger company Macrogen, Inc. This award is an example of the sequencing and multi-omics services Psomagen provides to federal agencies...
This federal contract award to Psomagen Inc., a for-profit organization and manufacturer, is for $48,825 to provide GENOTYPING SERVICES (DNA QC/MICROARRAY) to the National Institute on Aging, a civilian federal agency. The contract is a firm fixed-price purchase order with a performance period ending on January 6, 2026. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to support research and clinical applications. This contract is not...